胃切除与保留胃的Roux-en-Y重建治疗胃轻瘫的比较
回顾性比较胃切除与保留胃的Roux-en-Y重建治疗胃轻瘫,胃切除组30天并发症更多(44.4% vs 7.7%,p=0.001),但保留胃组后续需手术干预更多(23.1% vs 3.7%,p=0.04),中期症状改善无差异。
要点
- 胃切除组围术期并发症显著高于保留胃组(44.4% vs 7.7%,p=0.001)。
- 保留胃组后续需手术干预比例更高(23.1% vs 3.7%,p=0.04)。
- 两种术式在末次随访时胃轻瘫症状及评分无差异。
核心结论
- 胃切除与保留胃的Roux-en-Y重建在中期症状改善上等效,但胃切除围术期并发症更多,保留胃后续手术干预更多,胃切除可能更根治。
研究设计与样本
- 单中心回顾性队列研究,纳入2010年9月至2018年3月因胃轻瘫行Roux-en-Y重建的患者,排除既往胃切除或主要指征非胃轻瘫者。
主要发现
- 胃切除组既往因胃轻瘫接受干预的比例更高(63.0% vs 26.9%)。
- 保留胃组手术时间更短(155 vs 223 min)、出血更少(24 vs 130 mL)、住院更短(4.0 vs 7.2天)。
- 保留胃组后续因胃轻瘫需手术干预的比例更高(23.1% vs 3.7%,p=0.04)。
- 末次随访时两组报告的胃轻瘫症状或症状评分无差异。
临床怎么用
- 对于药物难治性胃轻瘫,选择术式需权衡围术期风险与远期再干预风险。
- 胃切除围术期并发症较高,保留胃的Roux-en-Y重建创伤更小但可能需后续手术。
局限性
- 胃切除组既往干预比例更高,可能影响并发症比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Gastroparesis is a debilitating functional disorder of the stomach marked by delayed gastric emptying in the absence of mechanical obstruction. Patients with severe, refractory symptoms may ultimately be managed with Roux-en-Y reconstruction; however, it is unclear whether the stomach should be left in situ, similar to a conventional gastric bypass, or resected as in gastrectomy. METHODS: All patients undergoing Roux-en-Y for the treatment of gastroparesis (GP) at our institution from September 2010 through March 2018 were retrospectively reviewed. Patients with prior gastric resection or whose primary operative indication was not gastroparesis were excluded from analysis. RESULTS: Twenty-six patients underwent Roux-en-Y with stomach left in situ (RY-SIS) and twenty-seven patients underwent gastrectomy with Roux-en-Y reconstruction during the study period. The mean age was 49.7 years in the RY-SIS cohort and 48.5 years in the gastrectomy cohort. Etiology of GP was similar between the two cohorts. Patients undergoing gastrectomy were more likely to have previous interventions for GP (63.0% vs. 26.9%). RY-SIS was associated with a shorter operative time (155 vs. 223 min), less blood loss (24 vs. 130 mL), and shorter length of stay (4.0 vs. 7.2 days). Twelve patients (44.4%) had complications within 30 days following gastrectomy compared to two patients (7.7%) following RY-SIS (p = 0.001). Patients in the RY-SIS cohort were more likely to require further subsequent surgical intervention for GP (23.1% vs. 3.7%, p = 0.04). At last follow-up, there were no differences in reported GP symptoms or symptom scoring. CONCLUSIONS: Gastrectomy was associated with greater perioperative morbidity compared to leaving the stomach in situ. Symptomatic improvement at intermediate follow-up was equivalent following either procedure. However, patients undergoing RY-SIS were more likely to require subsequent surgical intervention, suggesting that gastrectomy may be a more definitive operation for the management of medically refractory gastroparesis.
引用
- Landreneau JP, Strong AT, El-Hayek K, et al. Gastrectomy versus stomach left in situ with Roux-en-Y reconstruction for the treatment of gastroparesis. Surg Endosc. 2019. PMID: 31297624. doi:10.1007/s00464-019-06951-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。